Federal Register   DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 Schedules of Controlled Substances: Placement of Oliceridine in Schedule II–On August 7, 2020, the U.S. Food and Drug Administration approved a new drug application for oliceridine, chemically known as N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate. The Department of Health and Human Services […]

To access this content, you must be a Member.
Sign into your account or join to become a Member now.

Join Now